Skip to main navigation
About Us
Leadership
Board of Directors
Scientific Advisory Board
Our Medicines
Licensed Commercial Medicines
Expanded Access Policy
Pipeline
Clinical Trials
Anaphylm™
Libervant™
PharmFilm
PharmFilm® Technology
PharmFilm® Overview
Delivery Methods
Science
Advantages
Transmucosal Expertise
Collaborations
In-licensing
Out-licensing
Development & Licensee Services
Overview
Formulation Development
Analytical
Tech Transfer
Preclinical
Clinical
Regulatory
Commercial
Our Responsibility
Working With Healthcare Professionals
Code of Conduct
Sales And Marketing
Corporate Compliance
ESG Report 2022
Investors
Home
Press Releases
Events and Presentations
Scientific Events
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Events and Presentations
Libervant FDA Approval Conference Call
04.29.24 at 8:00 AM EDT
Click here for webcast
Email Alerts
Email Alerts
Investor Contact
Investor Contact
Investor FAQs
Investor FAQs
RSS Feeds
RSS Feeds
